Moderna stock price soars 160% on melanoma vaccine success
· businessinsider.com
Moderna has been looking for its next blockbuster drug after a wildly successful COVID era.
After making its name as a vaccine-maker during the COVID era, Moderna has been looking for its second act as a major drug developer. Investors seem to think it...